DEA Keeps Marijuana as a Schedule I Drug


August 11, 2016 (WASHINGTON) The Drug Enforcement Administration (DEA) has announced that they will keep marijuana as a schedule I drug. ,eating it will continue to be heavily restricted. According to the DEA Health and Human Services did review material and at present found the following.

  • Marijuana has a high potential for abuse. The HHS evaluation and the additional data gathered by the DEA show that marijuana has a high potential for abuse.
  •  Marijuana has no currently accepted medical use in treatment in the United States. Based on the established five-part test for making such determination, marijuana has no “currently accepted medical use” because: As detailed in the HHS evaluation, the drug’s chemistry is not known and reproducible; there are no adequate safety studies; there are no adequate and well-controlled studies proving efficacy; the drug is not accepted by qualified experts; and the scientific evidence is not widely available.
  •  Marijuana has no currently accepted medical use in treatment in the United States. Based on the established five-part test for making such determination, marijuana has no “currently accepted medical use” because: As detailed in the HHS evaluation, the drug’s chemistry is not known and reproducible; there are no adequate safety studies; there are no adequate and well-controlled studies proving efficacy; the drug is not accepted by qualified experts; and the scientific evidence is not widely available.

This means the drug will continue to be a schedule I drug under  “the statutory mandate of Title 21 United States Code, Section 812(b) (21 U.S.C. § 812(b)) is dispositive. Congress established only one schedule, Schedule I, for drugs of abuse with “no currently accepted medical use in treatment in the United States” and “lack of accepted safety for use . . . under medical supervision.” 21 U.S.C. § 812(b).”

Activists were hoping for a change in this, and an easing in policy. Time will tell. As more states legalize the use of the drug, if this regulatory standard will follow the path of prohibition.



Categories: Uncategorized

Tags: , ,

Leave a Reply

%d bloggers like this: